Welcome!

Web 2.0 Authors: Elizabeth White, Jason Bloomberg, Yeshim Deniz, Roger Strukhoff, Pat Romanski

News Feed Item

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Prospect Capital Corporation to Contact the Firm

NEW YORK, NY -- (Marketwired) -- 05/30/14 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Prospect Capital Corporation ("Prospect Capital" or the "Company") (NASDAQ: PSEC) of the July 28, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Prospect Capital and certain executives.

A complaint has been filed on behalf of all persons who purchased Prospect Capital securities between August 21, 2013 and May 6, 2014, inclusive (the "Class Period") in the Southern District of New York.

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

Specifically, the action alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Prospect Capital lacked adequate internal and financial controls; (ii) certain of Prospect Capital's wholly owned companies should have been accounted for as investment companies; (iii) Prospect Capital was required to consolidate these investment companies; (iv) as a result, the Company's reported investment income and financial results were misstated; and (v) as such, the Company's financial statements were not prepared in accordance with Generally Accepted Accounting Principles ("GAAP").

On May 6, 2014, after the market close, Prospect Capital filed its 10-Q for the third quarter of 2014 and disclosed that the SEC has asserted that some of Company's wholly owned companies are investment companies for accounting purposes and are required to be consolidated by the Company. Prospect Capital also announced that it may have to restate its prior financial statements to resolve the issue which would decrease the Company's historical net investment income.

Following this news, the Company's stock declined $0.54 per share, or over 5%, to close at $10.20 per share on May 7, 2014.

Request more information now by clicking here: www.faruqilaw.com/PSEC. There is no cost or obligation to you.

Take Action

If you invested in Prospect Capital stock or options between August 21, 2013 and May 6, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/PSEC. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Prospect Capital's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Email Contact
Telephone: (877) 247-4292 or (212) 983-9330

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.